1.
China Pharmacy
; (12)2001.
Article
de Chinois
| WPRIM
| ID: wpr-528030
RÉSUMÉ
0.05).The C/E were0.456and0.622,respectively.?C/?E was15.9.CONCLUSIONS:Deslo-ratadine has pharmacoeconomical advantages over mizolastine in treating chronic idiopathic urticaria.